Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1515 Articles

Jon C. Ogg | Jun 7, 2015 at 9:40 AM EDT

New Mega-Blockbuster Cholesterol Drug Class Faces Make-or-Break FDA Panels

This coming week is likely to be a serious one in the fight against cholesterol. FDA panels are evaluating more…

Lee Jackson | May 28, 2015 at 10:20 AM EDT

3 Top Value Stock Picks to Buy for This Week

Investors looking to move down in volatility but stay fully invested may want to consider moving capital to any of…

Chris Lange | May 28, 2015 at 9:30 AM EDT

Short Sellers More Selective on Big Pharma Stocks

The short interest data has been released for the May 15 settlement date and for the selected pharmaceutical stocks, short…

Lee Jackson | May 22, 2015 at 9:15 AM EDT

Jefferies Makes Changes to Top Pharmaceutical Stocks to Buy

With major mergers and acquisition deals happening, and a host of clinical trials that could offer some outstanding breakthrough drug…

Paul Ausick | May 13, 2015 at 4:01 PM EDT

The 4 Stocks That Drove the DJIA Down on Wednesday

thinkstockMay 13, 2015: Markets opened higher on Wednesday but were able to eke out just modest gains by the end…

Chris Lange | May 12, 2015 at 9:50 AM EDT

Short Sellers Keep Strong Bets Against Big Pharma

The April 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short…

Trey Thoelcke | May 12, 2015 at 6:28 AM EDT

The 5 Most Shorted NYSE Stocks in April

The five most shorted stocks trading on the New York Stock Exchange remained the same between the April 15 and…

Lee Jackson | May 8, 2015 at 9:20 AM EDT

4 Pharmaceutical Companies Leading the Breast Cancer Fight

In a new report, the RBC team focused on the companies that are making the most progress with treatments for…

Paul Ausick | May 6, 2015 at 4:01 PM EDT

The 4 Stocks That Weighed on the DJIA on Wednesday

thinkstockMay 6, 2015: Markets opened higher on Wednesday but soon sank as growth expectations for the U.S. economy dimmed again.…

Chris Lange | May 5, 2015 at 10:50 AM EDT

Top Credit Suisse Major Pharma Stock Picks to Buy

Credit Suisse has released a report that detailed its top picks for pharmaceutical stocks for the rest of 2015.

Jon C. Ogg | Apr 29, 2015 at 9:15 AM EDT

Top Analyst Upgrades and Downgrades: AK Steel, NOV, Pfizer, Stratasys, Twitter, Wynn and More

Wednesday's top analyst upgrades, downgrades and initiations include AK Steel, National Oilwell Varco, Pfizer, Stratasys, Twitter and Wynn Resorts.

Jon C. Ogg | Apr 28, 2015 at 8:00 AM EDT

Pfizer Dodges a Bullet on Earnings

Pfizer has reported better-than-expected first-quarter earnings and revenue and offered guidance.

Paul Ausick | Apr 27, 2015 at 4:01 PM EDT

The 4 Stocks That Sank the DJIA on Monday

thinkstockApril 27, 2015: Markets opened higher on Monday but there was little positive news to sustain the opening gains. Biotech…

Chris Lange | Apr 27, 2015 at 3:22 PM EDT

What to Expect From Merck and Pfizer Earnings

Pharmaceutical giants Merck and Pfizer are both releasing their first quarter financial results early Tuesday.

Trey Thoelcke | Apr 27, 2015 at 6:45 AM EDT

The 5 Most Shorted NYSE Stocks as Q2 Begins

Rising short interest in Petrobras kept its shares firmly in ranks of the most shorted stocks trading on the New…

1 … 61 62 63 64 65 … 101

Pfizer : PFE

All Pfizer Articles

New Mega-Blockbuster Cholesterol Drug Class Faces Make-or-Break FDA Panels

3 Top Value Stock Picks to Buy for This Week

Short Sellers More Selective on Big Pharma Stocks

Jefferies Makes Changes to Top Pharmaceutical Stocks to Buy

The 4 Stocks That Drove the DJIA Down on Wednesday

Short Sellers Keep Strong Bets Against Big Pharma

The 5 Most Shorted NYSE Stocks in April

4 Pharmaceutical Companies Leading the Breast Cancer Fight

The 4 Stocks That Weighed on the DJIA on Wednesday

Top Credit Suisse Major Pharma Stock Picks to Buy

Top Analyst Upgrades and Downgrades: AK Steel, NOV, Pfizer, Stratasys, Twitter, Wynn and More

Pfizer Dodges a Bullet on Earnings

The 4 Stocks That Sank the DJIA on Monday

What to Expect From Merck and Pfizer Earnings

The 5 Most Shorted NYSE Stocks as Q2 Begins

Warren Buffett Says He Now Likes “Four or Five” Businesses Berkshire Owns More than Alphabet. What Are They?

Samsung Reinvented Itself by Rethinking What It’s Worth. Retirees Who Do the Same Find Social Security Is Their Largest Asset.

The Portfolio Blueprint for Building $20,000 a Month in Dividend Income

Samsung Reinvented Itself by Rethinking What It's Worth. Retirees Who Do the Same Find Social Security Is Their Largest Asset.

The Portfolio Blueprint for Building $20,000 a Month in Dividend Income

Warren Buffett Says He Now Likes “Four or Five” Businesses Berkshire Owns More than Alphabet. What Are They?

Samsung Reinvented Itself by Rethinking What It’s Worth. Retirees Who Do the Same Find Social Security Is Their Largest Asset.

Pfizer : PFE

All Pfizer Articles

New Mega-Blockbuster Cholesterol Drug Class Faces Make-or-Break FDA Panels

3 Top Value Stock Picks to Buy for This Week

Short Sellers More Selective on Big Pharma Stocks

Jefferies Makes Changes to Top Pharmaceutical Stocks to Buy

The 4 Stocks That Drove the DJIA Down on Wednesday

Short Sellers Keep Strong Bets Against Big Pharma

The 5 Most Shorted NYSE Stocks in April

4 Pharmaceutical Companies Leading the Breast Cancer Fight

The 4 Stocks That Weighed on the DJIA on Wednesday

Top Credit Suisse Major Pharma Stock Picks to Buy

Top Analyst Upgrades and Downgrades: AK Steel, NOV, Pfizer, Stratasys, Twitter, Wynn and More

Pfizer Dodges a Bullet on Earnings

The 4 Stocks That Sank the DJIA on Monday

What to Expect From Merck and Pfizer Earnings

The 5 Most Shorted NYSE Stocks as Q2 Begins

Warren Buffett Says He Now Likes “Four or Five” Businesses Berkshire Owns More than Alphabet. What Are They?

Samsung Reinvented Itself by Rethinking What It’s Worth. Retirees Who Do the Same Find Social Security Is Their Largest Asset.

The Portfolio Blueprint for Building $20,000 a Month in Dividend Income

Featured Reads

Samsung Reinvented Itself by Rethinking What It's Worth. Retirees Who Do the Same Find Social Security Is Their Largest Asset.

The Portfolio Blueprint for Building $20,000 a Month in Dividend Income